The people ending psychiatry's guesswork.

Julien is a neuroscientist and entrepreneur. As Founder and Chief Executive Officer of OneCare Biotechnologies, he leads the development of the company's multi-omics blood-based diagnostics for psychiatry, overseeing scientific strategy, intellectual property, fundraising, and partnerships. His work combines neuroscience, biomarker discovery, and translational medicine with a drive to bring objective tools to mental health care. Recognized through multiple innovation and research awards, Julien believes precision medicine can transform psychiatric diagnosis and treatment. Outside of work, he enjoys reading and meditation.

Madline is a molecular biologist, entrepreneur, and postdoctoral researcher at the Université de Montréal with a Ph.D. in Molecular Biology. She previously co-founded SensÈn, where she led the development of a graphene biosensor platform for precision medicine. Following the integration of SensÈn into OneCare, she now serves as Vice President and Chief Product Officer, leading the development of the company's graphene biosensor platform while overseeing scientific strategy, partnerships, fundraising, operations, and commercialization. Passionate about translating breakthrough research into real-world healthcare solutions, Madline enjoys building multidisciplinary teams and has been recognized with several innovation and entrepreneurship awards. Outside of work, she enjoys running, practicing martial arts, and taking on new challenges.

Aiken is a technology entrepreneur and researcher with a background in engineering and clinical sciences. As Chief Technology Officer at OneCare Biotechnologies, he drives technical innovation, software development, and the integration of digital health solutions to improve healthcare accessibility. His multidisciplinary expertise bridges computer science, control engineering, and laboratory medicine, enabling him to build scalable platforms for complex health-tech challenges. Beyond engineering, Aiken explores emerging tech, digital healthcare trends, and multi-disciplinary systems.

Murielle is a molecular biologist, entrepreneur, and operations leader with over 15 years of experience spanning biomedical research, clinical development, and biotech innovation. As Chief Operating Officer at OneCare Biotechnologies, she translates scientific vision into scalable operational strategies driving next-generation diagnostic technologies. Murielle holds a Ph.D. in Human Genetics from McGill University, an M.Sc. from UQAM, and a B.Sc. from Georgia State University. She has led multidisciplinary teams, managed multimillion-dollar programs, and published peer-reviewed research. Outside of work, Murielle enjoys food, travel, and reading.

Daniel is the Chief Business Officer of OneCare Biotechnologies. He holds a Bachelor of Commerce with Distinction from McGill University, majoring in Finance, and has studied International Business to earn a Master's from HEC Montréal. At OneCare, he leads investor relations, grant writing, and strategic partnerships, working to bring the company's vision from the lab to the market. Before OneCare, he was a Financial Analyst at the Canadian Space Agency. Daniel believes the best businesses solve problems that genuinely matter. When he's not building OneCare, you'll find him deep in a good book or rolling dice at a Dungeons and Dragons table.

William is Chief of Staff at OneCare Biotechnologies, where he works closely with the leadership team to align priorities, drive execution, and support the company's day-to-day operations. He is currently pursuing an M.Sc.A. in Biotechnology at McGill University, and completed his undergraduate studies at the University of Guelph, where he was deeply involved in the campus startup and entrepreneurship community. Before transitioning to biotech, he brought a management and leadership background from his service in the Royal Canadian Navy. Outside of work, William enjoys playing badminton and performing with his band.